Global Inhalation Drug Delivery Devices Market US$ 14.9 Billion by 2021

The global inhalation drug delivery devices market expected to reach US$ 14.9 billion by 2021, growing at CAGR 1.2% over the forecast period 2017-2021, owing to rising prevalence of asthma, cystic fibrosis, and chronic obstructive pulmonary disease worldwide. North America accounted for the highest 54.8% share, followed by Europe 12.8% share of the global market. The key driving factors for growth include generic erosion, increasing incidence of pulmonary diseases and an increasing awareness of the inherent benefits offered by introduction of novel products.

The global asthma and chronic obstructive pulmonary disease (COPD) drugs market expected to reach US$ 57.5 billion by 2021, growing at CAGR 5.1% over the forecast period 2017-2021, whereas the global inhalation and nasal spray generic drugs market expected to reach US$ 34.2 billion by 2021, growing at CAGR 6.8% over the forecast period 2017-2021.
https://www.ihealthcareanalyst.com/report/inhalation-nasal-spray-generic-drugs-market/

Visit Inhalation Drug Delivery Devices Market by Device Type (Asthma Devices, COPD Devices), and Technology (Dry Powder Inhalers; Metered Dose Inhalers - Breath-actuated MDIs, Spacers for MDIs; Nebulizers) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/inhalation-drug-delivery-devices-market/

The global inhalation drug delivery devices market research report provides market size (Revenue USD Million 2014 to 2021), market share analysis, growth trends and forecast (CAGR%, 2017 to 2021). The global inhalation drug delivery devices market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. In addition, the global inhalation drug delivery devices market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments. Major players operating in the global inhalation drug delivery devices market and profiled in this report include Activaero GmbH, AstraZeneca Plc, Boehringer Ingelheim GmbH, Chiesi Farmaceutici SpA, GlaxoSmithKline Plc, Koninklijke Philips NV, Merck & Co, Inc., Monaghan Medical Corporation, Novartis AG, OMRON Healthcare Europe BV, PARI international, Pfizer, Inc., Roche Pharmaceuticals/F. Hoffman-La Roche Ltd., SkyePharma PLC/Vectura Group Plc, Sunovion Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd.

1. Device Type
1.1. Asthma Devices
1.2. COPD Devices

2. Technology
2.1. Dry Powder Inhalers (DPIs)
2.1.1. Metered Dose Inhalers (MDIs)
2.1.2. Breath-actuated MDIs
2.2. Spacers for MDIs
2.3. Nebulizers

3. Geography
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC
3.5. Rest of the World

4. Company Profiles
4.1. Activaero GmbH
4.2. AstraZeneca Plc
4.3. Boehringer Ingelheim GmbH
4.4. Chiesi Farmaceutici SpA
4.5. GlaxoSmithKline Plc
4.6. Koninklijke Philips NV
4.7. Merck & Co, Inc.
4.8. Monaghan Medical Corporation
4.9. Novartis AG
4.10. OMRON Healthcare Europe BV
4.11. PARI international
4.12. Pfizer, Inc.
4.13. Roche Pharmaceuticals/F. Hoffman-La Roche Ltd.
4.14. SkyePharma PLC/Vectura Group Plc
4.15. Sunovion Pharmaceuticals, Inc.
4.16. Teva Pharmaceutical Industries Ltd.

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/inhalation-drug-delivery-devices-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.